RxDoctor Payments Data

Jehan Helmi, MD

Child & Adolescent Psychiatry · Sanger, CANPI 1497986285

Payments from drug & device makers

$1,583in general payments, 2019–2025

Across 83 payments — averaging $19.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$443
  • AbbVie$273
  • E.r. Squibb & Sons, L.L.C.$240
  • Teva Pharmaceuticals USA, Inc.$228
  • Alkermes, Inc.$102
  • Luye Pharma (USA) Ltd.$69
  • plus $228 from 5 others

What the payments were for

  • Food & beverage$1,583100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,583 in reported general payments places this provider in the 80th percentile of 434 child & adolescent psychiatry providers in California.

See all child & adolescent psychiatry providers in California

Medicare billing

Part B allowed, 2024
$7,162
Medicare patients
29
Services billed
93

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate30$104,408
Abilify MaintenaAripiprazole23$69,434
VraylarCariprazine Hcl15$22,113
Paliperidone ErPaliperidone31$7,984
Aripiprazole41$4,252
Lurasidone Hcl26$3,688
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine20$2,203
Mirtazapine112$1,879
Divalproex Sodium44$1,839
Clozapine25$1,692
Hydroxyzine Hcl52$1,536
Oxcarbazepine11$1,493
Haloperidol30$1,233
Divalproex Sodium ErDivalproex Sodium16$1,119
Benztropine Mesylate55$894

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$66$104,40830 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$443$69,43423 claims
AbbVieVraylar$273$22,11315 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 434 child & adolescent psychiatry providers in California.

Other child & adolescent psychiatry in Sanger

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →